BIT Capital’s Genocea Biosciences, Inc. GNCA Stock Holding History

BIT Capital’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-35,000	Closed	-$43.8K	–	186
2022 Q1	$43.8K	Buy	+35,000	New	+$38.1K	﹤0.01%	118

Other funds holding GNCA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

BIT Capital's GNCA Position: Q2 2022 in Review

BIT Capital sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 35,000 shares — an estimated $43.8K sold.

BIT Capital first reported a position in GNCA in Q1 2022 and held it in 1 quarter. The position peaked at $43.8K in Q1 2022. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.

BIT Capital reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
BIT Capital sold 35,000 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $43.8K.
BIT Capital first reported a position in Genocea Biosciences, Inc. in Q1 2022 and held it in 1 quarter.
BIT Capital's Genocea Biosciences, Inc. position peaked at $43.8K in Q1 2022.
5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.

Based on BIT Capital's 13F filing for Q2 2022, filed 12 Feb 2025.